STEVIE (Safety Events In VIsmodEgib), a single-arm, open-label study on the safety of Hedgehog Pathway Inhibitors in advanced basal cell carcinoma Vismodegib: interim analysis of 150 patients

被引：0
|
作者：
Gutzmer, Ralf [1 ]
Leverkues, Martin [2 ,3 ]
Garbe, Claus [4 ]
Herbst, Rudolf [5 ]
Schadendorf, Dirk [6 ]
Kunstfeld, Rainer [7 ]
Hansson, Johan [8 ]
Basset-Seguin, Nicole [9 ]
Page, Damian [10 ]
Mitchell, Lada [10 ]
Hauschild, Axel [11 ]
机构：
[1] Hannover Med Sch, Hannover, Germany
[2] Univ Med Mannheim, Mannheim, Germany
[3] Univ Heidelberg, Med Fak Mannheim, D-6800 Mannheim, Germany
[4] Univ Klin Tubingen, Tubingen, Germany
[5] HELIOS Hauttumorzentrum, Erfurt, Germany
[6] Univ Klinikum Essen, Essen, Germany
[7] Med Univ Wien, Vienna, Austria
[8] Karolinska Univ Spital, Stockholm, Sweden
[9] Hop St Louis, Paris, France
[10] F Hoffmann La Roche & Cie AG, Basel, Switzerland
[11] Univ Klinikum Schleswig Holstein, Kiel, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2012年 / 10卷 / 09期
关键词：
D O I：
10.1111/j.1610-0387.2012.08008.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：677 / 677
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of levetiracetam in patients with refractory partial-onset seizures: Interim analysis of a multicentre, open-label single-arm study in Singapore
    Lim, S. H.
    Wilder-Smith, E.
    Loh, N.
    Tan, N.
    Pan, A.
    Puvanendran, K.
    EPILEPSIA, 2007, 48 : 114 - 114
  • [32] Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE study
    Johan Hansson
    Karen Bartley
    Thomas Karagiannis
    Jean-Jacques Grob
    Rainer Kunstfeld
    Brigitte Dréno
    Laurent Mortier
    Paolo A. Ascierto
    Lisa Licitra
    Caroline Dutriaux
    Luc Thomas
    Nicolas Meyer
    Bernard Guillot
    Reinhard Dummer
    Kate Fife
    D. Scott Ernst
    Yeun Mi Yim
    Natalie Dimier
    Alberto Fittipaldo
    Nicole Basset-Séguin
    Axel Hauschild
    European Journal of Dermatology, 2018, 28 : 775 - 783
  • [33] Real World Data on Efficacy and Safety of Vismodegib in Greek Patients with Advanced, Multiple and Metastatic Basal Cell Carcinoma
    Sgouros, Dimitrios
    Pappa, Georgia
    Syrmali, Anna
    Theodoropoulos, Konstantinos
    Theotokoglou, Sofia
    Bozi, Evangelia
    Damaskou, Vasileia
    Panayiotides, Ioannis G.
    Katoulis, Alexandros C.
    INDIAN JOURNAL OF DERMATOLOGY, 2022, 67 (06) : 796 - +
  • [34] Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials
    Anne Lynn S. Chang
    Sarah T. Arron
    Michael R. Migden
    James A. Solomon
    Simon Yoo
    Bann-Mo Day
    Edward F. McKenna
    Aleksandar Sekulic
    Orphanet Journal of Rare Diseases, 11
  • [35] Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials
    Chang, Anne Lynn S.
    Arron, Sarah T.
    Migden, Michael R.
    Solomon, James A.
    Yoo, Simon
    Day, Bann-Mo
    McKenna, Edward F.
    Sekulic, Aleksandar
    ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
  • [36] Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study)
    Mortier, Laurent
    Bertrand, Nicolas
    Basset-Seguin, Nicole
    Saiag, Philippe
    Dupuy, Alain
    Dalac-Rat, Sophie
    Guillot, Bernard
    Templier, Carole
    Desmedt, Eve
    Duhamel, Alain
    Guerreschi, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [37] The RegiSONIC Disease Registry Study: Safety and effectiveness of vismodegib or surgery as primary treatment in patients with locally advanced basal cell carcinoma
    Lacouture, M.
    Guillen, J.
    Kudchadkar, R.
    Rogers, G.
    Olencki, T.
    Tang, J. Y.
    Yoo, S.
    Dawson, K.
    Mun, Y.
    Sekulic, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S679 - S680
  • [38] Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma (BCC) treated with vismodegib in the STEVIE study
    Hansson, J.
    Bartley, K.
    Grob, J. J.
    Kuntsfeld, R.
    Dreno, B.
    Mortier, L.
    Ascierto, P. A.
    Licitra, L.
    Dutriaux, C.
    Jouary, T.
    Meyer, N.
    Guillot, B.
    Dummer, R.
    Fife, K.
    Ernst, D. S.
    Yim, Y. M.
    Williams, S.
    Fittipaldo, A.
    Basset-Seguin, N.
    Hauschild, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S680 - S681
  • [39] Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up
    Stratigos, Alexander J.
    Sekulic, Aleksandar
    Peris, Ketty
    Bechter, Oliver
    Prey, Sorilla
    Lewis, Karl D.
    Basset-Seguin, Nicole
    Chang, Anne Lynn S.
    Dalle, Stephane
    Orland, Almudena Fernandez
    Licitra, Lisa
    Robert, Caroline
    Ulrich, Claas
    Hauschild, Axel
    Migden, Michael R.
    Dummer, Reinhard
    Yoo, Suk-Young
    Okoye, Emmanuel
    Bassukas, Ioannis
    Loquai, Carmen
    De Giorgi, Vincenzo
    Eroglu, Zeynep
    Gutzmer, Ralf
    Ulrich, Jens
    Puig, Susana
    Inocencio, Timothy J.
    Chen, Chieh-, I
    Lafontaine, Patrick R.
    Seebach, Frank
    Lowy, Israel
    Fury, Matthew G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 90 (02) : 414 - 418
  • [40] Efficacy and Safety of Tracnil™ Administration in Patients with Dermatological Manifestations of PCOS: An Open-Label Single-Arm Study
    Ramanan, Ezhil Arasan
    Ravi, Sailatha
    Anbu, K. R. Radha
    Michael, Margaret
    DERMATOLOGY RESEARCH AND PRACTICE, 2020, 2020
12345